Skip to content

Establishment and application of dural blood flow evaluation technique based on non-invasive imaging (enhanced CT, MR) for chronic subdural hematoma

Establishment and application of dural blood flow evaluation technique based on non-invasive imaging (enhanced CT, MR) for chronic subdural hematoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052090
Enrollment
Unknown
Registered
2021-10-17
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma

Interventions

Chronic subdural hematomagroup:No
Control group:No

Sponsors

Beijing Tiantan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult, male or female, aged >= 18 years; 2. There are obvious neurological disorders before surgery, such as headache, dizziness, nausea and vomiting, limb numbness or weakness, unstable walking, limb twitching, unconsciousness, aphasia, unresponsiveness, decreased memory, etc.; 3. Patients with chronic subdural hematoma diagnosed by CT or MRI, and the brain tissue is significantly compressed and displaced (the cortex and/or midline are flattened and displaced by more than 5 mm); 4. The informed consent form has been signed.

Exclusion criteria

Exclusion criteria: 1. Head CT showed that the total amount of intracranial hematoma did not reach the indications for surgery; 2. Simultaneously combined with multiple system or organ dysfunction of the whole body, making the patient unable to tolerate the operation; 3. Definite coagulation function abnormality; 4. Women of childbearing age who have not taken effective contraceptive measures and have no negative pregnancy test records; 5. Patients who are undergoing experimental drug or instrumental trials.

Design outcomes

Primary

MeasureTime frame
Lumen diameter of middle meningeal artery;Middle meningeal artery flow velocity;Type of hematoma;

Countries

China

Contacts

Public ContactZhang Dong

Beijing Tiantan Hospital

zhangdong0660@aliyun.com+86 13801121292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026